Skip to main content
. 2024 Jan 11;111(1):znad421. doi: 10.1093/bjs/znad421

Table 1.

Patient characteristics

No opioids (n = 2962) Opioids (n = 1311) Total (n = 4273) P*
Age (years), median (i.q.r.) 48 (33–64) 52 (37–66) 50 (34–64) < 0.001†
Sex 0.033
 Female 1579 (53.3) 692 (52.8) 2271 (53.1)
 Male 1383 (46.7) 616 (47.0) 1999 (46.8)
 Other 0 (0) 3 (0.2) 3 (0.1)
ASA fitness grade < 0.001
 I 1377 (46.5) 386 (29.4) 1763 (41.3)
 II–III 1559 (52.6) 907 (69.2) 2466 (57.7)
 IV—V 24 (0.8) 15 (1.1) 39 (0.9)
 Missing 2 (0.1) 3 (0.2) 5 (0.1)
BMI (kg/m2) < 0.001
 Normal (18.5–24.9) 835 (28.2) 327 (24.9) 1162 (27.2)
 Overweight (25.0–29.9) 1078 (36.4) 385 (29.4) 1463 (34.2)
 Obese (30.0-39.9) 603 (20.4) 333 (25.4) 936 (21.9)
 Severely obese (>40.0) 111 (3.7) 94 (7.2) 205 (4.8)
 Underweight (< 18.5) 56 (1.9) 13 (1.0) 69 (1.6)
 Missing 279 (9.4) 159 (12.1) 438 (10.3)
Smoking status < 0.001
 Never smoked 1841 (62.2) 723 (55.1) 2564 (60.0)
 Current smoker 550 (18.6) 182 (13.9) 732 (17.1)
 Ex-smoker 355 (12.0) 307 (23.4) 662 (15.5)
 Missing 216 (7.3) 99 (7.6) 315 (7.4)
Procedure < 0.001
 Appendicectomy 522 (17.6) 241 (18.4) 763 (17.9)
 Cholecystectomy 880 (29.7) 346 (26.4) 1226 (28.7)
 Colorectal resection 271 (9.1) 122 (9.3) 393 (9.2)
 Inguinal hernia repair 440 (14.9) 136 (10.4) 576 (13.5)
 Nissen fundoplication 23 (0.8) 5 (0.4) 28 (0.7)
 Sleeve gastrectomy 49 (1.7) 21 (1.6) 70 (1.6)
 ACL repair 57 (1.9) 21 (1.6) 78 (1.8)
 Knee arthroplasty 110 (3.7) 147 (11.2) 257 (6.0)
 Hip arthroplasty 110 (3.7) 91 (6.9) 201 (4.7)
 Rotator cuff repair 11 (0.4) 11 (0.8) 22 (0.5)
 Shoulder arthroplasty 9 (0.3) 11 (0.8) 20 (0.5)
 Shoulder labral repair 12 (0.4) 1 (0.1) 13 (0.3)
 Cystectomy 28 (0.9) 4 (0.3) 32 (0.7)
 Nephrectomy 62 (2.1) 38 (2.9) 100 (2.3)
 Prostatectomy 66 (2.2) 35 (2.7) 101 (2.4)
 Hysterectomy 228 (7.7) 59 (4.5) 287 (6.7)
 Oophorectomy and salpingectomy 28 (0.9) 13 (1.0) 41 (1.0)
 Oophorectomy only 21 (0.7) 3 (0.2) 24 (0.6)
 Salpingectomy only 35 (1.2) 6 (0.5) 41 (1.0)
Surgical approach < 0.001
 MIS 1487 (50.2) 814 (62.1) 2301 (53.8)
 Open 1474 (49.8) 496 (37.8) 1970 (46.1)
 Missing 1 (0.0) 1 (0.1) 2 (0.0)
Indication 0.630
 Benign disease 2601 (87.8) 1144 (87.3) 3745 (87.6)
 Malignancy 360 (12.2) 167 (12.7) 527 (12.3)
  Missing 1 (0.0) 0 (0) 1 (0.0)
Urgency < 0.001
 Elective 2098 (70.8) 818 (62.4) 2916 (68.2)
 Emergency 863 (29.1) 493 (37.6) 1356 (31.7)
 Missing 1 (0.0) 0 (0) 1 (0.0)
Duration of surgery (min), median (i.q.r.) 80 (55–120) 98 (66–135) 87 (60–120) < 0.001†
Opioid use before surgery < 0.001
 No 2909 (98.2) 1180 (90.0) 4089 (95.7)
 Yes 53 (1.8) 131 (10.0) 184 (4.3)
Non-opioid analgesia use before surgery < 0.001
 No 2396 (80.9) 933 (71.2) 3329 (77.9)
 Yes 566 (19.1) 378 (28.8) 944 (22.1)
Clavien–Dindo grade of complication < 0.001
 None 2450 (82.7) 1025 (78.2) 3475 (81.3)
 I–II 487 (16.4) 265 (20.2) 752 (17.6)
 III–IV 21 (0.7) 20 (1.5) 41 (1.0)
 Missing 4 (0.1) 1 (0.1) 5 (0.1)
Duration of hospital stay (days), median (i.q.r.) 2 (1–3) 2 (1–3) 2 (1–3) 0.698†
OMEs consumed 24 h before discharge, median (i.q.r.) 0.0 (0.0–30.0) 35.0 (10.0–67.8) 9.0 (0.0–40.0) < 0.001†

Values are n (%) unless otherwise indicated. ACL, anterior cruciate ligament; MIS, minimally invasive surgery; OME, oral morphine equivalent. *χ2 test, except †Kruskal–Wallis test.